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1. Introduction 
For more than 95% of the patients with end-stage heart failure there is no definitive 
treatment option up to now (AHA, 2009). This fact is caused by a severe shortage in donor 
hearts on the one hand and on the other hand by technical and economic limitations of 
cardiac assist devices and artificial hearts. Thus there is a big need for alternative treatement 
options. Basically heart failure is due to the inability of adult cardiomyocytes to divide and 
repair damaged heart muscle. For myocardial regenerative medicine stem cells which show 
the ability to differentiate into functional cardiomyocytes might be a promising source. 
Although human embryonic stem cells can differentiate into beating cardiomyocytes (Xu et 
al, 2002), however the therapeutic use of these cells is not without legal and ethical 
problems. 
Previous studies in animal models have demonstrated the therapeutical potential of intra-
myocardial injection of adult murine stem cells. In a cell-cell contact dependent manner in 
mammals, mesenchymal stem cells aquired a cardiomyocyte phenotype (Orlic&Kocher 
2001, Kawamoto&Yeh 2003, Wang et. al., 2006). Furthermore spontaneously beating 
cardiomyocytes were derived from isolated cardiomyogenic cell lines of murine bone 
marrow stromal cells (Makino et al., 1999) adipose tissue stroma cells (Planat-Bernard et. al., 
2004) and from spermatogonial stem cells from the adult mouse testis (Guan et. al., 2006). In 
human myocardium however, adult stem cells from different origins applied 
intramyocardially did not show a differentiation into cardiomyocytes (Yoon&Wollert 2005). 
Thus, the search for an appropriate source of cells being able to differentiate into functional 
cardiomyocytes in human or to contribute to a contractile myocardial patch is still 
continuing. 
From adult rat pancreatic tissue multipotential stem cells were isolated and differentiated 
into the endodermal pancreatic and hepatic cells (Zulewski, 2001). Human pancreatic stem 
cells showed also a differentiation into mesodermal structures, like adipocytes, 
chondrocytes and osteocytes (Seeberger et. al., 2006). Furthermore rat and human pancreatic 
stem cells gave rise to cellular aggregates containing cell types of all three germ layers 
(Kruse et.al, 2004) including ectodermal lineages also shown in further recent publications 
(Seaberg et. al., 2004; Choi et. al., 2004). But up to now neither in animals nor in humans 
cardiomyocytes were generated from pancreatic stem cells. Due to the clinical need of 
cardiomyocytes, we investigated the differentiation of human pancreatic stem cell cultures 
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into cardiomyocytes, a process potentially promoted by co-culture with human myocardial 
biopsies.  
Myocardial regeneration with artificially applied cardiomyocytes is emerging to a 
promising issue of significant scientific and clinical impact. Nevertheless the source of cells 
for human cardiomyocyte differentiation especially from adult tissue is still unclear. We 
hypothesized that human pancreatic stem cells may differentiate into cardiomyocyte-like 
cells enhanced when co- cultured with myocardial tissue. 
2. Harvesting, isolating, culturing 
From four patients undergoing surgery after an abdominal injury, pancreatic tissue was 
obtained with informed consent (ethical accreditation of the Ethics Committees, University 
Hospital of Lübeck, AZ: 03-065). Stem cells were selected, cultured within fetal calf serum 
and passaged more than 21 times as described elsewhere (Kruse C et al., 2004). Briefly, the 
pancreatic tissue was treated with digestion medium containing HEPES-Eagle-medium (pH 
7.4), 0.1mM HEPES-buffer (pH 7.6), 70% (v/v) modified Eagle-medium, 0.5% (v/v) Trasylol 
(Bayer AG, Leverkusen, Germany), 1% (w/v) bovine serum albumin, 2.4 mM CaCl2 and 
collagenase (0.63 PZ/mg, Serva, Heidelberg, Germany). After digestion the acini were 
dissociated, centrifuged and further purified by washing in Dulbecco’s modified Eagle’s 
medium (DMEM, Gibco, Germany) supplemented with 20 % fetal calve serum (FCS). The 
washing procedure was repeated 5 times. The acini were resuspended in DMEM and 
cultured at 37°C in a 5% CO2 humidified atmosphere. After 1-2 days of culture spindle-
shaped stem cells were observed on the bottom of the cell culture flask. After reaching 
confluence pancreatic stem cells were subcultured by trypsinization, counted and reseeded 
with a density of 2-4 x 105 cells/cm2. This procedure was repeated until sufficient cells were 
available. For differentiation we used cells from passages 4 and 14. 
Pancreatic stem cells as a source of cardio-myocytes can be obtained from patients using 
minimally invasive procedure during laparoscopy. Due to their retroperitoneal topography 
this cell harvesting might not be as easy as obtaining cells from blood, bone marrow or fatty 
tissue. Nevertheless current investigations show that stem cells from salivary glands easier 
accessible than pancreatic tissue might have a comparable potential generating 
cardiomyocytes. On the other hand, if these pancreatic stem cells could react as a general 
donor on the basis of a recently postulated immunological compatibility of adult stem cells 
(Chiu RCJ, 2005; Puissant et. al, 2005) sophisticated harvesting might not be necessary. 
When cells became confluent in culture dishes netlike clusters could be detected. The cell 
layer was washed with the less nutritive phosphate buffered saline (PBS) and mechanically 
lifted partially from the culture bottom with a scraper.  
Irrespective of whether adult human pancreatic stem cells were cryo-conserved or freshly 
isolated, their phenotype built netlike cell clusters in different passages. After development 
of these netlike cell clusters, changing culture conditions and partial mobilization from the 
bottom, very few cell clusters showed distinct cellular autonomous contractions with about 
20 beats per minute. Contracting regions were then video documented in real time and 
reproduced in five settings. 
3. Co-culture with myocardium 
To promote self-differentiation into cardiomyocytes, human pancreatic stem cells were co-
cultured with biopsies of human myocardium. This  myocardial stimulation practically was 
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achieved by co- culture of the primary cells with each 5 pieces of myocardium (4x4x4mm) 
for 2 days. The tissue (left ventricular wall, mitral papillary muscle) was received during 
heart surgery (ethical accreditation of the Ethics Committees, University hospital of Lübeck, 
AZ 05-206). Heart muscle pieces were adhered to the bottom of the culture dishes for 3 
hours until primary pancreatic stem cells (1x 106) were applied. After 48h heart muscle 
pieces were removed and the stem cells were further cultured as described above. Cells 
were passaged every time after reaching confluence. Immunocytochemical analyses were 
performed directly 48 hours after treatment. To investigate the long term effects of 
differentiation, cells were collected 17 days after treatment for PCR- analyses. 
When cells became confluent in culture dishes netlike clusters could be detected. The cell 
layer was washed with the less nutritive phosphate buffered saline (PBS) and mechanically 
lifted partially from the culture bottom with a scraper. Contracting regions were then video 
documented in real time and reproduced in five settings. 
To test whether cardio-myocytes grow out of biopsies from heart tissues, we cultured them 
as described above but without pancreatic stem cells. After two days no outgrowing cells 
could be detected, thus cell fusion of cardio-myocytes from biopsies with pancreatic stem 
cells seems very unlikely. 
After having been in contact with human myocardium for 48 hours and growing for further 
14-40 days in co-culture, cells were partially mobilized from the bottom of the culture flask 
and treated with a less nutritive culture medium. Many contracting areas (4-6 fold) were 
found in comparison to the unstimulated cells. However, the structure of a contracting area 
itself was comparable with that already observed before having been developed 
spontaneously without contact to myocardium. These autonomous contractions with about 
20 beats per minute as well, were found in all five co-cultures investigated. 
The number of contracting areas was enhanced by co-cultured human myocardial biopsies. 
The influence from cardio-myocytes on glandular stem cells could become already 
demonstrated by an immunocytochemical visualization of sarcomeres (red) like shown in 
figure1 seeing a clearly detectable gradient from M, where the myocardium was located, to 
the periphery. This cellular stimulation could also be documented as described as follows. 
These findings of the stem cell transformation in contact with myocardium in-vitro may 
become repeated in-vivo after an intra-myocardial injection, 
4. Analysis of co-cultured glandular stem cells 
After co-culturing and breeding, the influence of the added myocardium to the glandular 
stem cells was examined by immunocytochemistry of sarcomere-related myosin, immuno-
cytochemistry of cardiac specific troponin, at the electrone-microscopic level and  
phenotyped with respect to RNA, protein and cardiomyocyte specificity. 
4.1 Immunocytochemistry of sarcomere-related myosin 
Both, the stimulated as well as the non stimulated stem cells were seeded on chamber slides 
and cultured for at least two days before they were fixed with methanol:acetone (7:3) 
containing 1 g/ml DAPI (Roche, Switzerland) and washed 3 times in PBS. After incubation 
in 10% normal goat serum at room temperature for 15 min the specimens were incubated 
with the primary antibody overnight at 4°C in a humid chamber. Primary monoclonal 
antibody was directed against sarcomere myosin MF 20 (DSHB, USA). After rinsing 3 times 
with PBS, slides were incubated for 45 minutes at 37°C with Cy3-labelled anti-mouse IgG, 
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diluted 1:200. Slides were washed 3 times in PBS, covered in Vectashield mounting medium 
(Vector, USA) and analyzed with a fluorescence microscope (Axioskop Zeiss, Germany). 
Excluding these detected sarcomeres were released from the biopsy and attached to the 
stem cells, controls with fibroblasts and endothelial cells were cocultured with myocardium. 
Within these controls, tested cells were negative for sarcomeres by immunocytochemistry.  
 
 
Fig. 1. Immunocytochemical visualization of sarcomeres (red) in transformed adult 
pancreatic stem cells (blue nuclei) which had been co-cultured with human myocardium 
(M) for two days . They were clearly positive for the tested antibody compared to the 
untreated pancreatic stem cells . A decreasing gradient of myosin containing cells from M to 
the periphery is to be seen 
4.2 Immunocytochemistry of cardiac specific troponin I 
Stem cells were co-cultured with myocardial biopsies for 48 hours and breeded for further 2 
to 4 days after removing the myocardium. Thereafter probes were rinsed 2 times with PBS 
and dried for 24 hours on air by RT and then fixated by pure acetone for 10 minutes and -
20C°, rinsed again for 2X5 minutes with tris-buffered-saline (TBS) and preincubated with 
RPMI 1640 (Sigma, USA) with 10% AB serum (Biochrom AG, Germany). Monoclonal anti-
troponin I antibody (Clone 2d5, Biozal 1:25) was used as the primary antibody for 60 
minutes. Secondary antibody administration (rabbit anti-mouse; DAKO, Denmark; 1:25 for 
30 minutes) followed by alkaline phosphatase anti-alkaline phosphatase complex incubation 
(DAKO, Denmark; 1:50, 30 minutes) was repeated for a total of times each. Finally, substrate 
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incubation (naphthole/neofuchsine) and counterstaining with hemalaun were performed 
before microscopic evaluation. Additionally an isotype-control was carried out with mouse 
IgG 1 (DAKO, Denmark) and for further negative control skeletal muscle was stained. 
Myocardium was used for a positive control.  An isotype-control with mouse IgG 1 (DAKO, 
Denmark) was negative as well. Additional controls applying on skeletal muscles were 
negative too. As expected, a control on human myocardium showed positive results (data 
not shown). 
 
 
Fig. 2. Human pancreatic adult stem cells with immunocytochemical staining of cardiospecific 
troponin I (left) and after a two day co-culture with human myocardium (right). The existance 
of cardiospecific troponin I in transformed cells is clearly demonstrated 
4.3 Electron microscopic evaluation 
Cells grown on coverslips were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer 
for 1 h. Postfixation was performed with 1% OsO4 in 0.1 M cacodylate buffer for 2 h; 
samples were dehydrated with ethanol and embedded in araldite (Fluka, Switzerland). 
Ultrathin sections were stained with uranyl acetate and lead citrate (Ultrostainer Carlsberg 
System, LKB, Sweden) and were examined with a Philips electron microscope EM 400 at 60 
kV (Philips, The Netherlands). 
 
a b
 
Fig. 3. Electron micrographs (magnification 13 000X) four days after a 48-hour contact with 
biopsies of human myocardium. Myofilaments and structures of  less (left) and complete 
developed intercalated disc (right) are demonstrated 
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Electron microscopy (Fig. 3 left) showed differentiated cardiomyocytes containing a number 
of contractile fibrils. Furthermore, different developmental stages of intercalated discs were 
observed. While intercalated discs are slightly but clearly recognizable (encircled, Fig. 3 left) 
in some cells, they are as well differentiated as in mature tissue in others (Fig. 3 right). 
4.4 Semiquantative RT-PCR analysis 
Total cellular RNA was isolated using NucleoSpin®RNA II-Kit (Macherey-Nagel, Germany). 
0.5 µg of total RNA was reverse transcribed into cDNA using Superscript II Reverse 
Transcriptase RNase H- (RT, Invitrogen, The Netherlands) and oligo dT-Primers (Invitrogen, 
The Netherlands) according to the manufacturer’s instructions. The PCR’s were performed 
in 50 µl reaction volume using Taq DNA Polymerase (MBI Fermentas GmbH, Germany). 
The reactions were carried out for 38 cycles. Control run of RNA without reverse 
transcriptions were performed to avoid contamination with genomic DNA and produced no 
bands. To normalize cDNA concentration in different RT-probes, we measured relative 
expression of GAPDH as representative for an internal housekeeping gene control. 
The expected  fragment sizes and optimal PCR annealing temperatures used were as 
follows: GAPDH , 5’:gagtcaacggatttggtcgt, 3’:ggaagatggtgatgggattt (213bp,  58,8°C), 
troponin T2, 5’:gattctggctgagaggagga, 3’:tggagactttctggttatcgttg (197bp, 62.6°C), alpha-actin, 
5’:gtgtgacgacgaggagacca, 3’:cttctgacccatacccacca (154bp, 62,6°C), desmin, 
5’:ctgtccctcccacctctgt, 3’:agcccctgctttctaagtcc (250bp, 62,6°C). A purified human heart RNA 
(Ambion, USA) and a carcinogenic cell line (HEp-2) served as functional controls for PCR- 
primer. PCR-analyses were carried out in a total of four settings. 
 
 
Fig. 4. Gene expression analysis with the specific PCR primers for the target genes α-actin, 
desmin and troponin T2 isoform1 demonstrated a greater increase of muscle cell-specific 
molecules in co-cultured beating cells (+) than in untreated beating cells (-).  Non beating 
carcinogenic cells did not show any muscle specific marker. As a positive control served 
human heart cDNA (heart) 
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To test the long-term effect of differentiation PCR-analyses were performed two weeks after 
co-culture. The target genes for α-actin, desmin and troponin T were detected to a 
somewhat greater extent in pancreatic stem cells cocultured with myocardium as compared 
to untreated cells (Fig. 4). Α-actin could partially not been amplified, whereas desmin and 
troponin T showed greater amounts in most of the experiments. It remains unclear why α-
actin is suppressed in some cultures. One explanation could be that the differentiation 
progression of single cell lines follows different roads. We could find a myocardial 
differentiation within 14 days, but also a shutdown of genes, e.g. α-actin, in between. Fig.4 
demonstrates typical results of these two possibilities. 
However, as the differences between co-culture and untreated cells were slightly, the 
differentiation seemed to abate during time. Probably a permanent stimulus might be 
necessary to keep the cells in differentiation processes. 
5. Homing 
Applying stem cell therapy in a failing myocardium, the dimension of an intra-myocardial 
cell homing is significant. Thus a comparison of the homing potential between glandular 
(GSCs) and mesenchymal stem cells (MSCs) was performed within the myocardium of a big 
animal model. 
In 6 African Bore Goats the intra- myocardial homing of glandular stem cells and MSCs 
(CD133+) was evaluated. Glandular stem cells were characterized by red PKH26 
respectively green PKH67 (MSCs) makers. Myocardial samples were taken after one resp. 
three hours (n=3), others were harvested 6 weeks after injection in additional three goats. 
Frozen tissue slices were generated and examined for the marked cells. 
 
 
Fig. 5. Through a left lateral thoracotomy and exposure of the left heart a mix of one million of 
each cell type was injected into three locations of the goat’s myocardium of the left ventricle 
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Fig. 6. a A mix of GSCs and MSCs (CD133+) are shown before intra- myocardial injection . 
GSCs  are characterized by red PKH26 respectively MSCs by green PKH67 (MSCs) makers. 
They stay within the cell membrane for about three months. Cell counts were performed 
after one and three hours and 6 weeks after the intra-myocardial injection 
Red PKH26 markers for glandular stem cells (GSCs) respectively  green PKH67 markers for 
mesenchymal stem cells (MSCs)  will enable to detect the intramyocardial injected stem cell 
within a time frame of six months. Within this time frame it should be possible to visualize 
connexin  anti-bodies for the  detection of gap junctions. 
Using a mix of an intra- myocardial injection of GSCs and MSCs, solely in MSCs (green) a 
significant cell migration into the surrounding myocardium (n=3) was observed. After 6 
weeks nearly all GSCs remained within the myocardium while the MSCs disappeared 
almost completely. Within the frozen myocardial slices >90% of the marked stem cells were 
identified as GSCs (red) but <10% as green MSCs.  
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Fig. 6. b  Mainly glandular stem cells (GSCs)  stained by red PKH26 were found six weeks 
after intramyocardial injection in the myocardium (blue)  of the Bore Goats (n=3). Due to a 
>90% homing of GSCs combined with the ability developing cardio- myocyte like cells, 
glandular stem cells might become a very promising treatment option in the therapy of a 
failing myocardium 
6. Clinical application 
Adult bone marrow derived adult stem cells i. e. mesenchymal stem cells (MSCs) were 
successfully applied clinically to restore the myocardium solely and  in combination with 
trans-myocardial laser (channels) for myocardial revascularization because MSCs mainly 
transform into capillaries ) but not significantly into cardio-myocytes. (Stamm C et al.,2003 
and Steinhoff G et al., 2006). 
Adult glandular stem cells (pancreatic, parotic and submandibular) however are able to 
form tissue with the distinct ability to generate cell types of all three germ layers (Kruse C et 
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al., 2004). We showed that mesenchymal cells from this tissue differentiate into cardio-
myocytes promoted in co-cultures with human myocardial biopsies (Guldner et al., 2006). 
 
 
Fig. 7. The concept of a glandular stem cell cardiomyoplasty is designed as a treatment 
option for end-stage heart failure. It combines an expected regenerative potential of 
transformed adult glandular stem cells into cardiomyocytes within the myocardium or onto 
the myocardium  and the potential of a hypercapillarized latissimus dorsi muscle (LDM) 
wrapped around the heart for stem cell nutrition and girdling. Muscle transformation from 
glandular stem cells into cardiomyocytes is documented. A hypercapillarization (capillary 
to fiber ratio) of 36% within the LDM was found after an intermittent electrical stimulation 
over 14 days by an implanted myostimulator delivering a controlled stimulation pattern by 
a new designed devise (Microstim myostimulator, Germany) 
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Harvesting pancreatic stem cells may cause severe complications due to pancreatic fistulas 
accompanied with a peritonitis. Biopsies of the glandula parotis may injure the facialis nerve 
with facialis paresis. The authors assume minor complications are to expect using the 
submandibular gland by harvesting cells. An amount of more than 100 mio. stem cells are 
expected from each submandibular gland, which can become harvested in the same 
operation injecting them into the myocardium. 
Glandular stem cells have the potential transforming into cardio myocytes (Guldner et al., 
2006). Furthermore GSCs showed a more than  90% homing  in comparison with MSCs after 
6 weeks injected in a goat’s myocardium (n=3). Combined with their ability developing 
cardio-myocyte like cells, glandular stem cells are expected to be superior to MSCs for 
myocardial repair. 
In goats and humans electrical continuous and intermittent stimulation of the latissimus 
dorsi muscle (LDM) has been shown to enhance capillary density of skeletal muscle tissue 
likewise in small animals as shown by Hudlicka O et al., 1984; Dawson JM et al., 1989; 
Mathieu-Costello et al., 1996; and Skorjanc D et al., 1998. Additionally known are data of 
capillary density in intermittent stimulated human sized animals, correlated with 
functional data like blood flow at rest and under exercise which were evaluated elsewhere 
(Guldner et al., 2008).The recent investigations in goats demonstrated a 36% higher 
capillary to fiber ratio in comparison with the non stimulated control after 14 days of 
electrical pacing of the in-situ LDM (Guldner et al., 2008). An electrically stimulated and 
therefore hyper-capillarized latissimus dorsi muscle (LDM) and wrapped around the 
heart could serve for GSC's  nutrition (Mannion et al., 1992, 1993, 1996 ;Salmons et al., 
1998; Guldner et.al.2008).   
A stem cell cardio-myoplasty combines a cellular cardio-myoplasty (Stamm et. al, 2003; 
Steinhoff&Stamm, 2006) with a muscular dynamic cardio-myoplasty (Carpentier& 
Chachques 1985). The additional elastic girdling from LDM around the heart (Figure 7) 
reduces left ventricular's wall tension and therefore reduces the oxygen consumption of the 
myocardium (Hagège A A et al., 1995). 
7. Conclusion 
These are first investigations demonstrating the feasibility of generating autonomously 
contracting cardio-myocyte-like cells from adult human glandular stem cells and their 
transformation in contact with myocardium. Injecting them into the myocardium is an in 
vivo co-culturing. We expect in opposite to the injection of bone marrow derived stem cells,  
resulting in capillaries, a substantial increase of cardiomyocytes. This mechanism might be 
helpful because of the inability of adult cardiomyocytes to divide and repair damaged heart 
muscle. 
Harvesting glandular stem cells intra-operatively might become feasible in the same 
operative procedure as the intramyocardial implantation likewise it has been practiced 
already with bone-marrow-derived stem cells (Steinhoff&Stamm, 2006). The estimated 
amount of harvested glandular stem cells from one glandular submandibularis might be 
many-fold higher than the amount of MSCs applied nowadays clinically. 
Regarding a superior intra-myocardial homing of GSCs in comparison to MSCs stem cell 
therapy with GSCs  might become an advanced cellular treatment option in the regenerative 
medicine for  end-stage heart failure. 
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Glandular stem cells might enable intramyocardial injections solely or in combination with a 
pre-stimulated cardiomyoplasty, a muscle powered cardiac assist procedure with an 
increased capillary to fiber ratio, which is to perform by adequate electrical stimulation 
patterns. This muscular indirect myocard revascularisation may not only increase 
myocardial`'s blood supply supporting the implanted GSCs but will additionally decrease 
the oxygen consumption by a girdling effect. This is due to a deceases wall tension of the 
myocardium. Thus glandular stem cells should enable a glandular stem cell 
cardiomyoplasty which combines an expected regenerative potential of transformed adult 
glandular stem cells into cardiomyocytes within the myocardium with the potential of a 
hypercapillarized latissimus dorsi muscle (LDM) wrapped around the heart for stem cell 
nutrition and girdling. 
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